Harbour Investments, Inc. Verona Pharma PLC Transaction History
Harbour Investments, Inc.
- $3.14 Billion
- Q3 2024
A detailed history of Harbour Investments, Inc. transactions in Verona Pharma PLC stock. As of the latest transaction made, Harbour Investments, Inc. holds 1,665 shares of VRNA stock, worth $64,235. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,665
Previous 1,500
11.0%
Holding current value
$64,235
Previous $21,000
123.81%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
151Shares Held
65.8MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$294 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$215 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$154 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$137 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$128 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.35B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...